Shares of Catalyst Pharmaceuticals slid 3.77% to $3.45 at 11:44 EST on Monday, after four consecutive sessions in a row of losses. The Nasdaq Stock Market is falling 1.21% to $12,601.30, following yesterday’s downward trend, This seems, up to now, an all-around negative trend exchanging session today.

Catalyst Pharmaceuticals’s last close was $3.58, 53.27% under its 52-week high of $5.28.

Catalyst Pharmaceuticals’s Sales

Catalyst Pharmaceuticals’s sales growth is 11.6% for the ongoing quarter and 4.6% for the next. The company’s growth estimates for the current quarter is 25% and a drop 10% for the next.

Catalyst Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth declined by 5.1%, now sitting on 118.18M for the twelve trailing months.

Catalyst Pharmaceuticals’s Stock Yearly Top and Bottom Value

Catalyst Pharmaceuticals’s stock is valued at $3.45 at 11:44 EST, way below its 52-week high of $5.28 and way above its 52-week low of $2.55.

Catalyst Pharmaceuticals’s Moving Average

Catalyst Pharmaceuticals’s value is below its 50-day moving average of $3.47 and below its 200-day moving average of $3.77.

LEAVE A REPLY

Please enter your comment!
Please enter your name here